the use of high-dose Advair for COPD

Glaxo will promote the use of high-dose Advair for COPD.

This is based on a new study comparing the combination of fluticasone and salmeterol (Advair) to salmeterol alone (Serevent).

It shows that high-dose Advair is better than Serevent in reducing exacerbations and the need for systemic steroids.

Practical advice for a better career, with unlimited access to CE

Pharmacy Technician's Letter Canada includes:

  • 12 issues every year, with brief articles about new meds and hot topics
  • 120+ CE courses, including the popular CE-in-the-Letter
  • Helpful, in-depth Technician Tutorials
  • Access to the entire archive

Already a subscriber? Log in

Volume pricing available. Get a quote